Symbols / HUM $198.39 +0.63% Humana Inc.
HUM Chart
About
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Healthcare Plans | Market Cap | 23.93B |
| Enterprise Value | 17.37B | Income | 1.19B | Sales | 129.66B |
| Book/sh | 146.42 | Cash/sh | 165.04 | Dividend Yield | 178.00% |
| Payout | 35.98% | Employees | 67060 | IPO | — |
| P/E | 20.16 | Forward P/E | 13.02 | PEG | — |
| P/S | 0.18 | P/B | 1.35 | P/C | — |
| EV/EBITDA | 4.87 | EV/Sales | 0.13 | Quick Ratio | 1.53 |
| Current Ratio | 2.00 | Debt/Eq | 74.81 | LT Debt/Eq | — |
| EPS (ttm) | 9.84 | EPS next Y | 15.24 | EPS Growth | — |
| Revenue Growth | 11.30% | Earnings | 2026-04-29 | ROA | 4.30% |
| ROE | 7.04% | ROIC | — | Gross Margin | 14.54% |
| Oper. Margin | -1.79% | Profit Margin | 0.92% | Shs Outstand | 120.05M |
| Shs Float | 120.29M | Short Float | 4.71% | Short Ratio | 2.96 |
| Short Interest | — | 52W High | 315.35 | 52W Low | 163.11 |
| Beta | 0.45 | Avg Volume | 2.07M | Volume | 1.59M |
| Target Price | $212.17 | Recom | Hold | Prev Close | $197.15 |
| Price | $198.39 | Change | 0.63% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-08 | main | Evercore ISI Group | In-Line → In-Line | $195 |
| 2026-04-07 | main | Wells Fargo | Equal-Weight → Equal-Weight | $227 |
| 2026-02-25 | main | Barclays | Equal-Weight → Equal-Weight | $176 |
| 2026-02-18 | main | Wells Fargo | Equal-Weight → Equal-Weight | $206 |
| 2026-02-17 | main | Goldman Sachs | Sell → Sell | $158 |
| 2026-02-17 | main | Truist Securities | Hold → Hold | $200 |
| 2026-02-13 | main | TD Cowen | Hold → Hold | $173 |
| 2026-02-12 | main | Jefferies | Buy → Buy | $235 |
| 2026-02-12 | main | UBS | Neutral → Neutral | $195 |
| 2026-02-12 | down | RBC Capital | Outperform → Sector Perform | $189 |
| 2026-02-12 | main | Guggenheim | Buy → Buy | $252 |
| 2026-02-12 | main | Cantor Fitzgerald | Neutral → Neutral | $201 |
| 2026-02-02 | down | Morgan Stanley | Equal-Weight → Underweight | $174 |
| 2026-01-07 | down | Wells Fargo | Overweight → Equal-Weight | $290 |
| 2026-01-05 | main | Barclays | Equal-Weight → Equal-Weight | $245 |
| 2025-12-18 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $262 |
| 2025-12-05 | up | Jefferies | Hold → Buy | $313 |
| 2025-11-25 | main | Barclays | Equal-Weight → Equal-Weight | $234 |
| 2025-11-10 | main | Truist Securities | Hold → Hold | $285 |
| 2025-11-07 | main | Deutsche Bank | Hold → Hold | $231 |
News
RSS: Latest HUM news- Humana Surges Above 50-Day MA. Should You Buy HUM Stock on CMS Rate Changes Here? - Barchart.com Wed, 08 Apr 2026 13
- Humana (NYSE:HUM) Stock Price Expected to Rise, Evercore Analyst Says - MarketBeat Wed, 08 Apr 2026 14
- Ohio pharmacists get paid to catch missed diabetes and blood pressure checks - Stock Titan Wed, 08 Apr 2026 12
- Humana Stock Surges 19%, With A 5-Day Winning Spree - Trefis Wed, 08 Apr 2026 04
- $HUM stock is up 8% today. Here's what we see in our data. - Quiver Quantitative ue, 07 Apr 2026 19
- Is Humana (HUM) Still Out Of Favor After Recent Share Price Rebound? - Yahoo Finance Wed, 08 Apr 2026 14
- Humana (HUM) Receives Raised Price Target from Evercore ISI Grou - GuruFocus Wed, 08 Apr 2026 17
- HUM Stock Today, April 8: Medicare Advantage Hike Drives Double-Digit Rebound - Meyka Wed, 08 Apr 2026 09
- Humana Stock Pops 11% As CMS Finalizes 2027 Medicare Advantage Rates - TIKR.com ue, 07 Apr 2026 17
- US to raise Medicare Advantage payments to insurers by 2.48% in 2027, insurance stocks surge - Reuters Mon, 06 Apr 2026 22
- UNH Stock vs HUM Stock: Which Wins on Medicare Rates? - EBC Financial Group ue, 07 Apr 2026 04
- Humana (HUM) Stock Surges 12% As Medicare Rate Blows Past Wall Street Expectations - MEXC ue, 07 Apr 2026 22
- UnitedHealth (UNH) vs. Humana (HUM): Which Healthcare Stock Is the Better Bet After the CMS Update? - TipRanks Wed, 08 Apr 2026 04
- Humana (HUM) Stock Rockets 12% on Medicare Advantage Payment Rate Revelation - MEXC Exchange ue, 07 Apr 2026 14
- Wells Fargo Raises Humana (HUM) Price Target to $227 | HUM Stock News - GuruFocus ue, 07 Apr 2026 15
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
129,664.00
+10.11%
|
117,761.00
+10.70%
|
106,374.00
+14.54%
|
92,870.00
|
| Operating Revenue |
|
129,664.00
+10.11%
|
117,761.00
+10.70%
|
106,374.00
+14.54%
|
92,870.00
|
| Other Operating Expenses |
|
15,901.00
+14.59%
|
13,877.00
+4.14%
|
13,325.00
+4.60%
|
12,739.00
|
| Total Expenses |
|
128,109.00
+10.40%
|
116,040.00
+12.67%
|
102,991.00
+15.33%
|
89,302.00
|
| Reconciled Depreciation |
|
824.00
-14.88%
|
968.00
+5.56%
|
917.00
+8.52%
|
845.00
|
| EBIT |
|
2,186.00
-8.19%
|
2,381.00
-38.57%
|
3,876.00
-2.34%
|
3,969.00
|
| Total Unusual Items |
|
-67.00
|
0.00
|
0.00
-100.00%
|
237.00
|
| Total Unusual Items Excluding Goodwill |
|
-67.00
|
0.00
|
0.00
-100.00%
|
237.00
|
| Special Income Charges |
|
-67.00
|
0.00
|
0.00
-100.00%
|
237.00
|
| Other Special Charges |
|
67.00
|
—
|
—
|
-237.00
|
| Net Income |
|
1,188.00
-1.57%
|
1,207.00
-51.51%
|
2,489.00
-11.30%
|
2,806.00
|
| Pretax Income |
|
1,555.00
-9.65%
|
1,721.00
-49.13%
|
3,383.00
-5.18%
|
3,568.00
|
| Net Non Operating Interest Income Expense |
|
-631.00
+4.39%
|
-660.00
-33.87%
|
-493.00
-22.94%
|
-401.00
|
| Interest Expense Non Operating |
|
631.00
-4.39%
|
660.00
+33.87%
|
493.00
+22.94%
|
401.00
|
| Net Interest Income |
|
-631.00
+4.39%
|
-660.00
-33.87%
|
-493.00
-22.94%
|
-401.00
|
| Interest Expense |
|
631.00
-4.39%
|
660.00
+33.87%
|
493.00
+22.94%
|
401.00
|
| Tax Provision |
|
250.00
-39.47%
|
413.00
-50.60%
|
836.00
+9.71%
|
762.00
|
| Tax Rate For Calcs |
|
0.00
-31.76%
|
0.00
+1.19%
|
0.00
+18.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-11.66
|
0.00
|
0.00
-100.00%
|
50.61
|
| Net Income Including Noncontrolling Interests |
|
1,203.00
-0.91%
|
1,214.00
-51.13%
|
2,484.00
-11.35%
|
2,802.00
|
| Net Income From Continuing Operation Net Minority Interest |
|
1,188.00
-1.57%
|
1,207.00
-51.51%
|
2,489.00
-11.30%
|
2,806.00
|
| Net Income From Continuing And Discontinued Operation |
|
1,188.00
-1.57%
|
1,207.00
-51.51%
|
2,489.00
-11.30%
|
2,806.00
|
| Net Income Continuous Operations |
|
1,203.00
-0.91%
|
1,214.00
-51.13%
|
2,484.00
-11.35%
|
2,802.00
|
| Minority Interests |
|
-15.00
-114.29%
|
-7.00
-240.00%
|
5.00
+25.00%
|
4.00
|
| Normalized Income |
|
1,243.34
+3.01%
|
1,207.00
-51.51%
|
2,489.00
-4.99%
|
2,619.61
|
| Net Income Common Stockholders |
|
1,188.00
-1.57%
|
1,207.00
-51.51%
|
2,489.00
-11.30%
|
2,806.00
|
| Diluted EPS |
|
9.84
-1.40%
|
9.98
-50.10%
|
20.00
-9.42%
|
22.08
|
| Basic EPS |
|
9.87
-1.40%
|
10.01
-50.17%
|
20.09
-9.50%
|
22.20
|
| Basic Average Shares |
|
120.45
-0.10%
|
120.57
-2.66%
|
123.87
-2.02%
|
126.42
|
| Diluted Average Shares |
|
120.83
-0.04%
|
120.87
-2.87%
|
124.44
-2.09%
|
127.09
|
| Diluted NI Availto Com Stockholders |
|
1,188.00
-1.57%
|
1,207.00
-51.51%
|
2,489.00
-11.30%
|
2,806.00
|
| Depreciation And Amortization In Income Statement |
|
698.00
-16.81%
|
839.00
+7.70%
|
779.00
+9.87%
|
709.00
|
| Earnings From Equity Interest Net Of Tax |
|
-102.00
-8.51%
|
-94.00
-49.21%
|
-63.00
-1475.00%
|
-4.00
|
| Loss Adjustment Expense |
|
110,812.00
+10.08%
|
100,664.00
+13.88%
|
88,394.00
+16.78%
|
75,690.00
|
| Net Policyholder Benefits And Claims |
|
110,812.00
+10.08%
|
100,664.00
+13.88%
|
88,394.00
+16.78%
|
75,690.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
48,909.00
+5.23%
|
46,479.00
-1.25%
|
47,065.00
+9.31%
|
43,055.00
|
| Cash Cash Equivalents And Short Term Investments |
|
19,903.00
-2.60%
|
20,435.00
-4.15%
|
21,320.00
+12.55%
|
18,942.00
|
| Cash And Cash Equivalents |
|
4,200.00
+89.10%
|
2,221.00
-52.68%
|
4,694.00
-7.25%
|
5,061.00
|
| Other Short Term Investments |
|
15,703.00
-13.79%
|
18,214.00
+9.55%
|
16,626.00
+19.78%
|
13,881.00
|
| Receivables |
|
3,270.00
+20.93%
|
2,704.00
+32.87%
|
2,035.00
+21.57%
|
1,674.00
|
| Accounts Receivable |
|
3,270.00
+20.93%
|
2,704.00
+32.87%
|
2,035.00
+21.57%
|
1,674.00
|
| Net PPE |
|
2,231.00
-11.89%
|
2,532.00
-16.44%
|
3,030.00
-5.93%
|
3,221.00
|
| Goodwill And Other Intangible Assets |
|
10,814.00
-2.34%
|
11,073.00
-1.51%
|
11,243.00
+3.08%
|
10,907.00
|
| Goodwill |
|
9,686.00
+0.57%
|
9,631.00
+0.85%
|
9,550.00
+4.46%
|
9,142.00
|
| Other Intangible Assets |
|
1,128.00
-21.78%
|
1,442.00
-14.83%
|
1,693.00
-4.08%
|
1,765.00
|
| Investments And Advances |
|
16,834.00
-12.92%
|
19,332.00
+8.92%
|
17,748.00
+18.24%
|
15,010.00
|
| Long Term Equity Investment |
|
638.00
-8.46%
|
697.00
-5.81%
|
740.00
-1.20%
|
749.00
|
| Total Liabilities Net Minority Interest |
|
31,172.00
+3.79%
|
30,034.00
-2.32%
|
30,747.00
+11.06%
|
27,685.00
|
| Payables And Accrued Expenses |
|
15,990.00
-0.70%
|
16,102.00
-6.18%
|
17,163.00
+15.97%
|
14,800.00
|
| Payables |
|
15,990.00
-0.70%
|
16,102.00
-6.18%
|
17,163.00
+15.97%
|
14,800.00
|
| Accounts Payable |
|
15,684.00
-0.10%
|
15,699.00
-6.61%
|
16,810.00
+15.92%
|
14,502.00
|
| Other Payable |
|
306.00
-24.07%
|
403.00
+14.16%
|
353.00
+18.46%
|
298.00
|
| Current Debt And Capital Lease Obligation |
|
0.00
-100.00%
|
577.00
-60.01%
|
1,443.00
-54.78%
|
3,191.00
|
| Current Debt |
|
0.00
-100.00%
|
577.00
-60.01%
|
1,443.00
-54.78%
|
3,191.00
|
| Other Current Borrowings |
|
—
|
—
|
0.00
-100.00%
|
500.00
|
| Long Term Debt And Capital Lease Obligation |
|
12,369.00
+10.99%
|
11,144.00
+9.12%
|
10,213.00
+28.71%
|
7,935.00
|
| Long Term Debt |
|
12,369.00
+10.99%
|
11,144.00
+9.12%
|
10,213.00
+28.71%
|
7,935.00
|
| Non Current Deferred Liabilities |
|
356.00
+36.92%
|
260.00
-2.26%
|
266.00
-6.99%
|
286.00
|
| Non Current Deferred Revenue |
|
356.00
+36.92%
|
260.00
-2.26%
|
266.00
-6.99%
|
286.00
|
| Stockholders Equity |
|
17,657.00
+7.83%
|
16,375.00
+0.69%
|
16,262.00
+6.21%
|
15,311.00
|
| Common Stock Equity |
|
17,657.00
+7.83%
|
16,375.00
+0.69%
|
16,262.00
+6.21%
|
15,311.00
|
| Capital Stock |
|
33.00
+0.00%
|
33.00
+0.00%
|
33.00
+0.00%
|
33.00
|
| Common Stock |
|
33.00
+0.00%
|
33.00
+0.00%
|
33.00
+0.00%
|
33.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
198.72
+0.00%
|
198.72
+0.01%
|
198.69
+0.01%
|
198.67
|
| Ordinary Shares Number |
|
120.59
-0.04%
|
120.64
-1.29%
|
122.22
-2.20%
|
124.97
|
| Treasury Shares Number |
|
78.13
+0.07%
|
78.08
+2.11%
|
76.47
+3.76%
|
73.69
|
| Additional Paid In Capital |
|
3,600.00
+3.96%
|
3,463.00
+3.50%
|
3,346.00
+3.08%
|
3,246.00
|
| Retained Earnings |
|
29,075.00
+2.68%
|
28,317.00
+2.82%
|
27,540.00
+8.03%
|
25,492.00
|
| Gains Losses Not Affecting Retained Earnings |
|
-633.00
+40.67%
|
-1,067.00
-6.81%
|
-999.00
+23.39%
|
-1,304.00
|
| Treasury Stock |
|
14,418.00
+0.33%
|
14,371.00
+5.22%
|
13,658.00
+12.36%
|
12,156.00
|
| Minority Interest |
|
80.00
+14.29%
|
70.00
+25.00%
|
56.00
-5.08%
|
59.00
|
| Other Equity Adjustments |
|
-633.00
+40.67%
|
-1,067.00
-6.81%
|
-999.00
+23.39%
|
-1,304.00
|
| Total Equity Gross Minority Interest |
|
17,737.00
+7.86%
|
16,445.00
+0.78%
|
16,318.00
+6.17%
|
15,370.00
|
| Total Capitalization |
|
30,026.00
+9.11%
|
27,519.00
+3.94%
|
26,475.00
+13.89%
|
23,246.00
|
| Invested Capital |
|
30,026.00
+6.87%
|
28,096.00
+0.64%
|
27,918.00
+5.60%
|
26,437.00
|
| Total Debt |
|
12,369.00
+5.53%
|
11,721.00
+0.56%
|
11,656.00
+4.76%
|
11,126.00
|
| Net Debt |
|
8,169.00
-14.01%
|
9,500.00
+36.46%
|
6,962.00
+14.79%
|
6,065.00
|
| Net Tangible Assets |
|
6,843.00
+29.06%
|
5,302.00
+5.64%
|
5,019.00
+13.96%
|
4,404.00
|
| Tangible Book Value |
|
6,843.00
+29.06%
|
5,302.00
+5.64%
|
5,019.00
+13.96%
|
4,404.00
|
| Commercial Paper |
|
—
|
0.00
-100.00%
|
871.00
+46.39%
|
595.00
|
| Current Notes Payable |
|
0.00
-100.00%
|
577.00
+0.87%
|
572.00
-72.71%
|
2,096.00
|
| Investments In Other Ventures Under Equity Method |
|
638.00
-8.46%
|
697.00
-5.81%
|
740.00
-1.20%
|
749.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
921.00
-68.95%
|
2,966.00
-25.50%
|
3,981.00
-13.21%
|
4,587.00
|
| Cash Flow From Continuing Operating Activities |
|
921.00
-68.95%
|
2,966.00
-25.50%
|
3,981.00
-13.21%
|
4,587.00
|
| Net Income From Continuing Operations |
|
1,203.00
-0.91%
|
1,214.00
-51.13%
|
2,484.00
-11.35%
|
2,802.00
|
| Depreciation |
|
773.00
-14.87%
|
908.00
+6.82%
|
850.00
+13.48%
|
749.00
|
| Amortization Cash Flow |
|
51.00
-15.00%
|
60.00
-10.45%
|
67.00
-30.21%
|
96.00
|
| Depreciation And Amortization |
|
824.00
-14.88%
|
968.00
+5.56%
|
917.00
+8.52%
|
845.00
|
| Amortization Of Intangibles |
|
51.00
-15.00%
|
60.00
-10.45%
|
67.00
-30.21%
|
96.00
|
| Other Non Cash Items |
|
—
|
108.00
-4.42%
|
113.00
+61.43%
|
70.00
|
| Stock Based Compensation |
|
241.00
+16.43%
|
207.00
+18.29%
|
175.00
-18.98%
|
216.00
|
| Asset Impairment Charge |
|
156.00
-64.30%
|
437.00
+67.43%
|
261.00
+5.24%
|
248.00
|
| Deferred Tax |
|
75.00
+139.06%
|
-192.00
-14.97%
|
-167.00
-67.00%
|
-100.00
|
| Deferred Income Tax |
|
75.00
+139.06%
|
-192.00
-14.97%
|
-167.00
-67.00%
|
-100.00
|
| Operating Gains Losses |
|
219.00
+212.86%
|
70.00
-40.17%
|
117.00
+517.86%
|
-28.00
|
| Gain Loss On Investment Securities |
|
50.00
+308.33%
|
-24.00
-144.44%
|
54.00
-73.66%
|
205.00
|
| Change In Working Capital |
|
-1,797.00
-1266.88%
|
154.00
+90.12%
|
81.00
-84.83%
|
534.00
|
| Change In Receivables |
|
-570.00
+14.80%
|
-669.00
-98.52%
|
-337.00
-524.07%
|
-54.00
|
| Change In Payables And Accrued Expense |
|
-472.00
-337.19%
|
199.00
-78.25%
|
915.00
-6.15%
|
975.00
|
| Change In Payable |
|
-472.00
-337.19%
|
199.00
-78.25%
|
915.00
-6.15%
|
975.00
|
| Change In Account Payable |
|
-472.00
-337.19%
|
199.00
-78.25%
|
915.00
-6.15%
|
975.00
|
| Change In Other Working Capital |
|
96.00
+1700.00%
|
-6.00
+70.00%
|
-20.00
-162.50%
|
32.00
|
| Change In Other Current Assets |
|
-2,173.00
-316.65%
|
1,003.00
+176.10%
|
-1,318.00
-184.67%
|
-463.00
|
| Change In Other Current Liabilities |
|
1,322.00
+454.42%
|
-373.00
-144.35%
|
841.00
+1811.36%
|
44.00
|
| Investing Cash Flow |
|
2,273.00
+177.00%
|
-2,952.00
+15.46%
|
-3,492.00
-247.12%
|
-1,006.00
|
| Cash Flow From Continuing Investing Activities |
|
2,273.00
+177.00%
|
-2,952.00
+15.46%
|
-3,492.00
-247.12%
|
-1,006.00
|
| Net PPE Purchase And Sale |
|
-523.00
+7.92%
|
-568.00
+28.46%
|
-794.00
+29.11%
|
-1,120.00
|
| Purchase Of PPE |
|
-546.00
+5.04%
|
-575.00
+42.73%
|
-1,004.00
+11.70%
|
-1,137.00
|
| Sale Of PPE |
|
23.00
+228.57%
|
7.00
-96.67%
|
210.00
+1135.29%
|
17.00
|
| Capital Expenditure |
|
-546.00
+5.04%
|
-575.00
+42.73%
|
-1,004.00
+11.70%
|
-1,137.00
|
| Net Investment Purchase And Sale |
|
2,982.00
+263.22%
|
-1,827.00
+25.88%
|
-2,465.00
-9.56%
|
-2,250.00
|
| Purchase Of Investment |
|
-6,440.00
+21.32%
|
-8,185.00
-8.38%
|
-7,552.00
-24.85%
|
-6,049.00
|
| Sale Of Investment |
|
9,422.00
+48.19%
|
6,358.00
+24.99%
|
5,087.00
+33.90%
|
3,799.00
|
| Net Business Purchase And Sale |
|
34.00
+138.20%
|
-89.00
+61.80%
|
-233.00
-109.86%
|
2,364.00
|
| Purchase Of Business |
|
-81.00
+8.99%
|
-89.00
+61.80%
|
-233.00
+30.86%
|
-337.00
|
| Gain Loss On Sale Of Business |
|
67.00
|
0.00
|
0.00
+100.00%
|
-237.00
|
| Net Other Investing Changes |
|
-220.00
+52.99%
|
-468.00
|
—
|
—
|
| Financing Cash Flow |
|
-1,215.00
+51.15%
|
-2,487.00
-190.54%
|
-856.00
+55.28%
|
-1,914.00
|
| Cash Flow From Continuing Financing Activities |
|
-1,215.00
+51.15%
|
-2,487.00
-190.54%
|
-856.00
+55.28%
|
-1,914.00
|
| Net Issuance Payments Of Debt |
|
431.00
+60.82%
|
268.00
-43.93%
|
478.00
+134.29%
|
-1,394.00
|
| Issuance Of Debt |
|
1,481.00
-35.10%
|
2,282.00
-21.58%
|
2,910.00
+46.82%
|
1,982.00
|
| Repayment Of Debt |
|
-1,050.00
+47.86%
|
-2,014.00
+17.19%
|
-2,432.00
+27.96%
|
-3,376.00
|
| Long Term Debt Issuance |
|
1,481.00
-33.65%
|
2,232.00
-12.26%
|
2,544.00
+28.36%
|
1,982.00
|
| Long Term Debt Payments |
|
-948.00
+14.36%
|
-1,107.00
+52.53%
|
-2,332.00
+22.27%
|
-3,000.00
|
| Net Long Term Debt Issuance |
|
533.00
-52.62%
|
1,125.00
+430.66%
|
212.00
+120.83%
|
-1,018.00
|
| Short Term Debt Issuance |
|
0.00
-100.00%
|
50.00
-86.34%
|
366.00
|
0.00
|
| Short Term Debt Payments |
|
-102.00
+88.75%
|
-907.00
-807.00%
|
-100.00
+73.40%
|
-376.00
|
| Net Short Term Debt Issuance |
|
-102.00
+88.10%
|
-857.00
-422.18%
|
266.00
+170.74%
|
-376.00
|
| Net Common Stock Issuance |
|
-151.00
+81.52%
|
-817.00
+48.06%
|
-1,573.00
+24.95%
|
-2,096.00
|
| Common Stock Payments |
|
-151.00
+81.52%
|
-817.00
+48.06%
|
-1,573.00
+24.95%
|
-2,096.00
|
| Common Stock Dividend Paid |
|
-430.00
+0.23%
|
-431.00
+0.00%
|
-431.00
-9.95%
|
-392.00
|
| Cash Dividends Paid |
|
-430.00
+0.23%
|
-431.00
+0.00%
|
-431.00
-9.95%
|
-392.00
|
| Repurchase Of Capital Stock |
|
-151.00
+81.52%
|
-817.00
+48.06%
|
-1,573.00
+24.95%
|
-2,096.00
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
—
|
—
|
| Net Other Financing Charges |
|
-1,285.00
+33.25%
|
-1,925.00
-387.31%
|
670.00
-65.96%
|
1,968.00
|
| Changes In Cash |
|
1,979.00
+180.02%
|
-2,473.00
-573.84%
|
-367.00
-122.02%
|
1,667.00
|
| Beginning Cash Position |
|
2,221.00
-52.68%
|
4,694.00
-7.25%
|
5,061.00
+49.12%
|
3,394.00
|
| End Cash Position |
|
4,200.00
+89.10%
|
2,221.00
-52.68%
|
4,694.00
-7.25%
|
5,061.00
|
| Free Cash Flow |
|
375.00
-84.32%
|
2,391.00
-19.68%
|
2,977.00
-13.71%
|
3,450.00
|
| Interest Paid Supplemental Data |
|
628.00
+7.53%
|
584.00
+48.22%
|
394.00
+11.30%
|
354.00
|
| Income Tax Paid Supplemental Data |
|
231.00
-54.35%
|
506.00
-43.96%
|
903.00
+19.13%
|
758.00
|
| Earnings Losses From Equity Investments |
|
102.00
+8.51%
|
94.00
+49.21%
|
63.00
+1475.00%
|
4.00
|
| Sale Of Business |
|
115.00
|
0.00
|
0.00
-100.00%
|
2,701.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-03 View
- 42026-04-02 View
- 42026-04-02 View
- 8-K2026-03-09 View
- 8-K2026-03-02 View
- 42026-02-26 View
- 42026-02-26 View
- 42026-02-25 View
- 42026-02-25 View
- 42026-02-24 View
- 10-K2026-02-19 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-17 View
- 8-K2026-02-11 View
- 42026-01-12 View
- 42026-01-05 View
- 42026-01-05 View
- 42026-01-05 View
- 42026-01-05 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|